BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 26073188)

  • 21. Comparisons in the changes of clinical characteristics and cerebrospinal fluid cytokine profiles between varicella-zoster virus meningitis/encephalitis and other central nervous system infections.
    Ma C; Lu Y; Zhang Q; Chen H; Zhang Q; Hu H; Song Z; Chen R; Liu D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 47(10):1345-1354. PubMed ID: 36411685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurological complications of varicella-zoster virus infection in adults with human immunodeficiency virus infection.
    De La Blanchardiere A; Rozenberg F; Caumes E; Picard O; Lionnet F; Livartowski J; Coste J; Sicard D; Lebon P; Salmon-Cèron D
    Scand J Infect Dis; 2000; 32(3):263-9. PubMed ID: 10879596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis of herpesvirus infections of the central nervous system.
    Boivin G
    Herpes; 2004 Jun; 11 Suppl 2():48A-56A. PubMed ID: 15319090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between viral load of varicella zoster virus in cerebrospinal fluid and the clinical course of central nervous system infection.
    Rottenstreich A; Oz ZK; Oren I
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):174-7. PubMed ID: 24666705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Varicella-zoster virus infections].
    Lilie HM; Wassilew SW
    Hautarzt; 2004 Sep; 55(9):831-40. PubMed ID: 15316637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in the treatment of varicella-zoster virus infections.
    Andrei G; Snoeck R
    Adv Pharmacol; 2013; 67():107-68. PubMed ID: 23886000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Varicella zoster virus encephalomyelitis as a late complication following haematopoietic stem cell transplantation.
    Shahani L
    BMJ Case Rep; 2014 Dec; 2014():. PubMed ID: 25527690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acyclovir-induced neurotoxicity with a positive cerebrospinal fluid varicella zoster PCR result creating a management dilemma: a case report.
    Robertson KM; Harvey CL; Cunningham JM
    J Med Case Rep; 2020 Sep; 14(1):156. PubMed ID: 32943113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella Zoster viral encephalitis without herpes: diagnosis by metagenomic next-generation sequencing of cerebrospinal fluid.
    Hong X; Ji Y; Chen M; Su F; Zhu Y; Ge Y
    Future Microbiol; 2023 Nov; 18():1217-1223. PubMed ID: 37882765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella-zoster virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1.
    Grahn A; Studahl M; Nilsson S; Thomsson E; Bäckström M; Bergström T
    Clin Vaccine Immunol; 2011 Aug; 18(8):1336-42. PubMed ID: 21697341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation.
    Umezawa Y; Kakihana K; Oshikawa G; Kobayashi T; Doki N; Sakamaki H; Ohashi K
    Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The protean manifestations of varicella-zoster virus vasculopathy.
    Gilden DH; Mahalingam R; Cohrs RJ; Kleinschmidt-DeMasters BK; Forghani B
    J Neurovirol; 2002 Dec; 8 Suppl 2():75-9. PubMed ID: 12491155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of both herpes simplex and varicella-zoster viruses in cerebrospinal fluid from patients with encephalitis.
    Casas I; Tenorio A; de Ory F; Lozano A; Echevarría JM
    J Med Virol; 1996 Sep; 50(1):82-92. PubMed ID: 8890045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central nervous system infections produced by varicella zoster virus.
    Nagel MA; Niemeyer CS; Bubak AN
    Curr Opin Infect Dis; 2020 Jun; 33(3):273-278. PubMed ID: 32332223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prognostic value of VZV PCR in cerebrospinal fluid in neurological manifestations of varicella].
    Levy M; Hentgen V; Marque-Juillet S; Fiot E; Fagherazzi G; Nathanson S; Foucaud P
    Arch Pediatr; 2015 May; 22(5):491-7. PubMed ID: 25819633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central nervous system complications of varicella-zoster virus.
    Science M; MacGregor D; Richardson SE; Mahant S; Tran D; Bitnun A
    J Pediatr; 2014 Oct; 165(4):779-85. PubMed ID: 25063723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Luminometric microplate hybridization for detection of varicella-zoster virus PCR product from cerebrospinal fluid.
    Koskiniemi M; Mannonen L; Kallio A; Vaheri A
    J Virol Methods; 1997 Jan; 63(1-2):71-9. PubMed ID: 9015277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of a "wide-range" quantitative nested real-time PCR assay for varicella zoster virus myelitis.
    Takahashi T; Tamura M; Takasu T
    J Med Virol; 2013 Nov; 85(11):2042-55. PubMed ID: 23934732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass-spectrometric profiling of cerebrospinal fluid reveals metabolite biomarkers for CNS involvement in varicella zoster virus reactivation.
    Kuhn M; Sühs KW; Akmatov MK; Klawonn F; Wang J; Skripuletz T; Kaever V; Stangel M; Pessler F
    J Neuroinflammation; 2018 Jan; 15(1):20. PubMed ID: 29343258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging drugs for varicella-zoster virus infections.
    Andrei G; Snoeck R
    Expert Opin Emerg Drugs; 2011 Sep; 16(3):507-35. PubMed ID: 21699441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.